Compositions comprising zinc and antimicrobial agent
Patent Information
- Application Number
- IN202227075307
- Authority / Receiving Office
- IN · IN
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-06-24
- Filing Date
- 2022-12-25
- Publication Date
- 2026-10-07
- Estimated Expiration
- 2041-06-17
AI Technical Summary
Current oral care products, such as toothpastes and mouthwashes, provide only short-term antimicrobial benefits due to rapid reduction in active ingredient concentration, leading to limited long-term effectiveness in controlling oral malodour caused by bacterial growth.
A composition combining a bipolar antimicrobial particle with an asymmetric 1:1 or 2:1:1 clay particle and zinc, where the antibacterial agent is a quaternary ammonium compound, synergistically interacting to provide extended antimicrobial benefits and malodour control.
The synergistic interaction between the bipolar antimicrobial particle and zinc results in a composition that effectively reduces oral malodour by decreasing volatile sulphurous compounds, offering prolonged antimicrobial benefits and improved oral hygiene.
Abstract
Description
Field of the InventionThe present invention relates to antimicrobial home care and personal carecompositions in which the antimicrobial efficacy could manifest itself in e.g., inhibition ofbacterial growth, malodour control or even extended or longer-lasting hygiene benefits.The composition may be embodied in a variety of formats, such as a toothpaste, oreven a hard surface cleaning composition.Background of the InventionA variety of microorganisms are present in our environment. They may be bacteria,viruses or even protozoans. While some microorganisms are useful to humanbeings, and some are commensals, a wide variety of microorganisms areundesired, but they inhabit many animate and inanimate surfaces that are ofconcern to human beings.Usually such undesired microorganisms multiply quickly and their biological activitymay manifest itself as e.g., malodour on certain animate surfaces and eveninanimate surfaces. For example, when it comes to human skin, control of malodourassumes importance, for example in the underarm, on feet, as well as on the scalp,and hair. Malodour control is also important in the context of on laundered textilesand on hard surfaces, such as the toilet bowl and dishes.A wide variety of home care and personal care compositions are used for anequally wide range of applications, including for preventing, stopping or controllingmicrobial activity so that certain unwanted effects could in turn be prevented,stopped or controlled.Certain bacteria are known to cause malodour, example body odour, underarmmalodour and oral malodour.Generally, malodour is caused by bacterial activity which creates certainmalodourous compounds that are called as volatile sulphurous compounds such ashydrogen sulphide, methyl mercaptans, dimethyl sulphide, 3-mercapto-2-methyl-butan-1-ol and 3-mercapto-3-methylhexan-1-ol, ammonia and amines for exampletrimethylamine, putrescene (1,4-diaminobutane), indole, skatole (3-methyliondole),pyrazine; aldehydes, for example acrolein and butanal, alcohols for example oct-1-en-3-ol, ketones for example oct-1-en-3-one. On the other hand, malodourouscompounds commonly found in sweat include volatile fatty acids (VFAs) andelectrolytes such as isovaleric acid, 3-methyl-2-hexenoic acid and 4-methyloctanoicacid.Malodor of the oral cavity is also known as halitosis or bad breath. It is a commonnon-therapeutic condition that can be mitigated by use of toothpastes or othercosmetic oral care compositions. In extreme cases, halitosis could become atherapeutic condition necessitating the use of prescription oral care products.It is generally believed that the cause of this condition is due to anaerobic bacteria,especially gram-negative anaerobic bacteria, in the mouth. These bacteria generatevolatile sulfur compounds (VSC's) which are known to cause oral or breath malodor.It is also recognized in the art that oral malodor not only comes from the posteriordorsal surface of the tongue but also from periodontal pockets. Furthermore, aperson with gingivitis or periodontal disease may have increased oral malodor fromdisintegrated epithelial cells. Epithelial cells turn over faster if inflammation ispresent. Therefore, a larger number of these dead epithelial cells remain in the oralcavity and degrade into the malodorous compounds.functions of a dentifrice, amouthwash and similar products include those of neutralising and / or removingunpleasant odours in the mouth and of making the user feel confident aboutfreshness of the breath.Dentifrice compositions like toothpastes, which are a type of personal carecompositions, usually quickly neutralise and dislodge the odour-causing compoundsand for a short period thereafter, do also mask remnants of any odorous compounds.Any enhancement in efficacy of such dentifrice compositions is highly desired.The addition of substances having antibacterial / antimicrobial properties to toothpastesand mouthwashes, and the effect thereof, are well known. However, the effect of theactive substances is only short-term, since the concentration of the substance inquestion drops rapidly following oral hygiene, and microbial development and bacterialgrowth set in again immediately. In this context it has been found that commercial oralcare products display limited long-term effect in the oral cavity and that, for example, alarge proportion of the active ingredients is removed from the mouth by rinsing withwater after cleaning the teeth, for example, or by drinking or by consuming food. As aresult of this, for example, oral malodour cannot be prevented over a prolonged period.US2009010857 A (Unilever) discloses toothpastes comprising calcium carbonate asabrasive, water and zinc salt substantially all of which is in the form of water-solubilised zinc citrate.WO17167535 A1 (Unilever) discloses toothpaste compositions having zinc salt forproviding antimicrobial benefits, also having calcium-based abrasive, smectite clay anda buffering agent.WO9939685 A1 (Unilever) discloses an oral care composition is provided in the form ofa transparent gel, comprising an abrasive silica, a thickening silica, a polyol-humectant-containing liquid vehicle, and a low level of sodium bicarbonate. Despite the presenceof the bicarbonate, the product is a transparent gel or white paste, and provides for ateeth-whitening effect, as well as a reduction of oral malodour, and neutralizes the acid,formed in the oral cavity by microbial decomposition of sugar. The composition may becoloured, and different compositions with different colours, e.g. a blue or a white one,may be dispensed from a single or a multicompartment container.WO2003 / 002056 (Church And Dwight Co Inc) discloses an oral composition havingantibacterial effective amount of cetylpyridinium chloride and guarhydroxypropyltrimonium chloride to bind to compounds which undesirably bind tocetylpyridinium chloride thereby enabling the cetylpyridinium chloride to effectively bindto tooth surfaces and perform an antibacterial function.A bipolar clay based antimicrobial particle has been disclosed in US2012 / 0177712 A1(Unilever). The precursor of the particle is an asymmetric 1:1 or 2:1:1 clay particlecomprising alternating tetrahedral and octahedral sheets terminating with a tetrahedralsheet at one external surface plane and an octahedral sheet at another externalsurface plane with an antimicrobial group attached to the coordinating cation on one ofthe said external surface plane selected from a quaternary ammonium materialcomprising a single alkyl or alkenyl long chain having an average chain length greaterthan or equal to C20, or a quaternary ammonium material.WO14102032 A1 (Unilever) discloses oral care compositions having the bipolarantimicrobial particle as above and where the antibacterial agent is a quaternaryammonium material. The compositions control bacterial re-growth and provideimmediate control on the bacterial count. The compositions comprise chalk or anycalcium-based abrasive.Summary of the InventionWe have now surprisingly determined that the aforesaid bipolar antimicrobial particleinteracts synergistically with a compound of zinc, such as zinc sulphate, to provide avariety of antimicrobial benefits inter alia to control or mitigate malodour, especially oralmalodour.Accordingly, this synergistic interaction can be provided to consumers in the form of avariety of home care and personal care compositions.In accordance with a first aspect is disclosed a composition comprising:(i) 0.1 to 10 wt% of a bipolar antimicrobial particle whose precursor is anasymmetric 1:1 or 2:1:1 clay particle comprising alternating tetrahedral andoctahedral sheets terminating with a tetrahedral sheet at one external surfaceplane and an octahedral sheet at another external surface plane with anantibacterial agent attached to the coordinating cation on one of the said externalsurface plane, where the antibacterial agent is a quaternary ammoniumcompound; and,(ii) 0.001 to 10 wt% of a compound of zinc, wherein the median diameter of saidparticles (D50) is 0.1 to 10 μm.Preferably the composition is a home care composition. Alternatively, it is a personalcare composition.In accordance with a second aspect is disclosed non-therapeutic use of a compositionof the first aspect in the form of an oral care composition for an improvement in oralhygiene.In accordance with a third aspect is disclosed a non-therapeutic method of improvingoral hygiene comprising a step of applying a composition of the first aspect in the formof an oral care composition in the oral cavity.In accordance with a further aspect is disclosed a packaged oral care productcomprising a composition of the first aspect in the form of an oral care composition in apackage, preferably with a set of instructions to use the composition.Detailed DescriptionThese and other aspects, features and advantages will become apparent to those ofordinary skill in the art from a reading of the following detailed description and theappended claims. For the avoidance of doubt, any feature of one aspect of the presentinvention may be utilised in any other aspect of the invention. The word "comprising" isintended to mean "including" but not necessarily "consisting of" or "composed of." Inother words, the listed steps or options need not be exhaustive. It is noted that theexamples given in the description below are intended to clarify the invention and arenot intended to limit the invention to those examples per se. Similarly, all percentagesare weight / weight percentages unless otherwise indicated. Except in the operating andcomparative examples, or where otherwise explicitly indicated, all numbers in thisdescription and claims indicating amounts of material or conditions of reaction, physicalproperties of materials and / or use are to be understood as modified by the word"about". Numerical ranges expressed in the format "from x to y" are understood toinclude x and y. When for a specific feature multiple preferred ranges are described inthe format "from x to y", it is understood that all ranges combining the differentendpoints are also contemplated.A "home care composition" is a composition used for the treatment, cleaning, caring orconditioning of the home or any of its contents. The foregoing includes, but is notlimited to, compositions, products, or combinations thereof relating to or having use orapplication in the treatment, cleaning, cleansing, caring or conditioning of surfaces,furniture and atmosphere of the home and household contents, such as clothes, fabricsand / or cloth fibers and the manufacture of all of the foregoing products.A "personal care composition" is a composition for the treatment, cleaning, caring orconditioning of the person. The foregoing includes, but is not limited to, chemicals,compositions, products, or combinations thereof relating to or having use or applicationin the treatment, cleaning, cleansing or conditioning of the person (including inparticular the skin, hair and oral cavity), and the manufacture of all the foregoing.All references to the term / expression wt% or % by weight, shall mean percentage byweight of the composition, except where indicated otherwise."Oral care composition" refers to a composition for which the intended use can includeoral care, oral hygiene, or oral appearance, or for which, the intended method of usecan comprise administration to the oral cavity. In some embodiments, an oral carecomposition is not intentionally swallowed, but is rather retained in the oral cavity for atime sufficient to affect the intended utility. The oral care compositions as disclosedherein may be used in nonhuman mammals such as companion animals (e.g., dogsand cats), as well as by humans. In some embodiments, the oral care compositions asdisclosed herein are used by humans.Halitosis is the technical term for bad breath or malodour. It is common and may affectthe quality of life. Sometimes people who have bad breath may remain unaware. Oralmalodor is caused by microbial action that leads to production of volatile sulfurcompounds ("VSC") namely hydrogen sulphide, methylmercaptan and dimethylsulphide. Therefore, treatment, which may be cosmetic (non-therapeutic) or may evenbe therapeutic, is often directed towards reduction of microorganisms inside the oralcavity or neutralization of the VSC compounds or by masking the malodour. A varietyof oral care compositions available in a variety of formats are used for this purpose.The two most common formats or products are toothpastes and mouthwash. Suchcompositions usually contain one or more active ingredients included from e.g.,0.05 wt% to as high as 10 wt% of the composition. However, some actives may notreach the target site partly because they do not bind to the desired surface.In some cases the active or actives may easily wash away and are therefore notretained for long periods in the oral cavity. Accordingly, there is a need for oral carecompositions that allow that counteract malodour or reduce the malodour for extendedperiod.Oral malodour can be evaluated or measured by a variety of techniques. These includesubjective assessments by human judges (organoleptic evaluations), industrial sulfidemonitoring instruments which analyze exhaled air or microbial specimens removedfrom the mouth and gas chromatography of exhaled air, or bacterial specimensremoved from the mouth. Another way is to identify hydrogen sulfide (H2S)-producingbacteria among tongue biofilm microflora and to investigate the relationship betweenbacterial flora and H2S levels in mouth air. Oral malodour can be assessed by gaschromatography, and Breathtron and organoleptic scores., Another way is to use aportable sulfide monitor, the Halimeter.We have used soft tissue model to determine the efficacy of oral care compositions inaccordance with this invention.The procedure, is as follows:Soft tissue model is an ex-vivo model that measures volatile sulphurous compoundsgenerated by salivary bacteria. The method involves collection of early morning salivafrom volunteers having good general and oral health. The saliva is pooled, oralepithelial cells are separated, sterilized and layered on the surface of agarose in a 12well plate. Mixed salivary bacteria are then added in the plate. This is followed bytreatment with the oral care composition, in this case, toothpaste samples. Cysteine-HCl is added post treatment as a precursor for volatile sulphurous compounds. Leadacetate paper is placed over the plate to act as an indicator of the volatile sulphurouscompounds that are generated. The dark coloration of the lead acetate paper isrecorded using a reflectometer in the form of L* a* b* values and the differencebetween the initial and final L* a* b* values [ΔE], is used as a quantitative measure ofthe volatile sulphurous compounds so formed. Lower ΔE indicates a more efficaciouscomposition.ΔE = √(Li-Lf)2 + (ai - af)2 + (bi - bf)2Preferably the data is statistically analysed using the Tukey-Kramer analysis comparingthe mean measurements for the 3 repeats.Formulation scientists have many options to choose from because a wide variety ofactive ingredients ranging from flavours to plant-based actives and to chemicals suchas compounds of zinc. For longer-lasting activity, the usual approach is to increase thedosage of the ingredient concerned. However, that may lead to secondary problemslike instability or may even affect some other desirable property of the compositions.For example, an excess of an ingredient may make the formulation unpalatable or tooastringent. As the compositions of the invention can be personal care compositions,and particularly oral care compositions, a good mouthfeel would be preferred byconsumers.A variety of compounds of zinc are used in for example, oral care compositions. Themost common ones are zinc sulphate and zinc citrate. The present applicant hasdisclosed oral care compositions that comprise bipolar antimicrobial particle that hasbeen referred to earlier. The aforesaid materials each provide one or more technicaleffects as referred to earlier. However, we have now surprisingly observed that whenused in combination, the two materials counteract malodour or reduce the malodour.It is known that a set of technical features is regarded as a combination of features ifthe functional interaction between the features achieves a combined technical effectwhich is different from, e.g. greater than, the sum of the technical effects of theindividual features. In other words, the interaction of the individual features produces asynergistic effect. This is different from a mere aggregation of features or properties.It is believed that the bipolar antimicrobial particle and the compound of zinc interactsynergistically to provide a combined effect that is not a simple additive effect.Accordingly, in accordance with a first aspect is disclosed a composition comprising:(i) 0.1 to 10 wt% of a bipolar antimicrobial particle whose precursor is anasymmetric 1:1 or 2:1:1 clay particle comprising alternating tetrahedral andoctahedral sheets terminating with a tetrahedral sheet at one external surfaceplane and an octahedral sheet at another external surface plane with anantibacterial agent attached to the coordinating cation on one of the said externalsurface plane, where the antibacterial agent is a quaternary ammoniumcompound; and,(ii) 0.001 to 10 wt% of a compound of zinc, wherein the median diameter of saidparticles (D50) is 0.1 to 10 μm.Preferably the composition is a home care composition. More preferably the home carecomposition is a laundry detergent, a fabric conditioner, a floor cleaning composition, atoilet cleaning composition, a dishwash composition or a surface sanitisingcomposition.Alternatively, the composition is a personal care composition. Preferably such apersonal care composition is a leave-on skin lotion, cream, antiperspirant, deodorant,lipstick, foundation, mascara, sunless tanner, sunscreen, serum, shampoo, hairconditioner, hair serum, hair gel, oral care composition, handwash, bodywash, showergel or soap.It is preferred that in the antimicrobial particle, said antibacterial agent is attached tocoordinating cations on the external surface of the octahedral surface plane.When the particles are of an increased size, the available surface area is believed tobe lower. Accordingly, as the preferred particles have significantly lower size, isbelieved that more area is available for the antibacterial agent to form adduct therewith.Without further being bound by theory, it is believed that this makes more effective useof the antibacterial agent, thereby providing opportunity for substantial reduction in thedosage of the antibacterial agent. While conventional antibacterial agents need anoptimised dosage of 0.2 to 0.5 wt%, the antibacterial agent, delivered in the form of thedisclosed bipolar antibacterial particle, is seen to be highly effective even at an (actual)dosage of 0.001 %.While not wishing to be further bound by theory it is believed that the preferred particlesare appropriately sized to fit inside the interstitial spaces on the surface of the teethwhich is believed to be a reason for prolonged efficacy. It is further believed thatparticles of lower size reduce, to a significant extent, any unfavorable interactionbetween the anionic surfactant and antibacterial agent even when the particle containse.g., cetyl pyridinium chloride which is a quaternary ammonium compound and this isalso believed to be a cause for longer lasting antibacterial benefits.Particles of lower size also provide an effective mechanism for an increased loading ofthe antibacterial agent, if so desired.Particle size distribution (D50) is also known as the median diameter or the mediumvalue of the particle size distribution, it is the value of the particle diameter at 50 % inthe cumulative distribution. It is an important parameter characterizing particle size. Forexample, if D50=5.8 μm, then 50 % of the particles in the sample are larger than5.8 μm, and 50 % smaller than 5.8 μm. D50 is usually used to represent the particlesize of group of particles. The D50 is the size in microns that splits the distribution withhalf above and half below this diameter.The precursor of the antibacterial particle with bipolar topospecific characteristics ispreferably an asymmetric 1:1 or 2:1:1 clay particle having alternating tetrahedral andan octahedral sheets terminating with a tetrahedral and an octahedral sheet at exteriorsurface planes. Particle of 1:1 clay is particularly preferred as the precursor. Preferred1:1 clays include kaolinite and serpentine subgroups of minerals. The species includedwithin the kaolinite subgroup include but are not limited to kaolinite, dickite, halloysiteand nacrite. The species within the serpentine subgroup include but are not limited tochrysolite, lizardite, and amesite. Preferred 2:1:1clays include chlorite group ofminerals. The chlorite comprises tetrahedral-octahedral-tetrahedral sheets like 2:1clays, with an extra weakly bound brucite like layer between tetrahedral layers. Thetetrahedral sheet preferably comprises coordinating tetrahedral cations of silicon. Thetetrahedral sheet may also include isomorphously substituted coordinating tetrahedralcations which are not silicon. Isomorphously substituted coordinating tetrahedralcations include, but are not limited to, cations of aluminum, iron or boron.The octahedral sheet preferably has coordinating octahedral cation of aluminum. Theoctahedral sheet may also comprise isomorphously substituted coordinating octahedralcations which are not aluminium. Isomorphously substituted coordinating octahedralcations include cations of magnesium or iron. It is preferred that the antimicrobial agentis attached to the coordinating cations on the exterior side of one of the externalsurface planes. Accordingly, the antimicrobial agent is attached to coordinating cationson the exterior side of the tetrahedral sheet. Alternatively, the antimicrobial molecule isattached to the coordinating cations on the exterior side of the octahedral sheet.Coordinating cations on the exterior side of each of the tetrahedral and the octahedralsurface sheets are attached to a antimicrobial molecule, with the proviso that theantimicrobial molecule attached to the coordinating cations on the exterior side of thetetrahedral surface sheet is not identical to the molecule attached to the coordinatingcations on the exterior side of the octahedral surface sheet. The antimicrobial agent ispreferably attached to the coordinating cations on the external surface of theoctahedral surface plane and is not preferably attached to coordination cations of non-exterior tetrahedral or octahedral plane or on the interior side of the surface sheets.In the above mentioned particulate antimicrobial the clay:antibacterial ratio is from1:0.001 to 1:1 more preferably from 1:0.001 and 1:0.1. It is preferred that in theantimicrobial particle, the antibacterial agent is attached to coordinating cations on theexternal surface of the octahedral surface plane.Further preferably in every 100 parts of said bipolar antimicrobial particle comprisesfrom 0.05 to 20 parts, more preferably 0.1 to 10 parts by weight of said antibacterialagent. The median diameter of said particles (D50) is 0.1 to 10 μm, preferably morepreferably 0.4 to 1 μm and most preferably 0.5 to 0.8 μm.It is further preferred that the quaternary ammonium material is at least one ofcetylpyridinium chloride (CPC), cetyltrimethylammonium chloride (CTAC),cetyltrimethylammonium bromide (CTAB), benzalkonium chloride (BKC), benzethoniumchloride, cetrimide, quaternium, tetrabutyl ammonium bromide, undecylenamidopropyltrimonium methosulphate, methylbenzethonium chloride, cetethyldimoniumbromide, cetromonium tosylate, cocotrimonium chloride, dodecylbenzyltrimoniumchloride, lauryl isoquinolium bromide, laurylpyridinium chloride, dequalinium chloride ordomiphen bromide. More prererably the quaternary ammonium material is selectedfrom cetylpyridinium chloride (CPC), cetyltrimethylammonium chloride (CTAC),cetyltrimethylammonium bromide (CTAB), benzalkonium chloride (BKC), benzethoniumchloride, cetrimide or quaternium.A particularly preferred antibacterial agent is Cetylpyridinium chloride. The antibacterialactivity of cetylpyridinium chloride is, without being bound to the theory, believed to belinked to the cationic charge of its amine group. Thus, cetylpyridinium chloride isattracted to and binds to negatively-charged protein moieties on the cell membrane orcell wall of the microorganism and to tooth surfaces which are also typically negativelycharged. The resulting attachment to microorganisms disrupts the cell wall structurecausing leakage of the intracellular fluids, eventually killing the associatedmicroorganism. However, cetylpyridinium chloride is generally not effective in manysystems because of its tendency to complex with component that carry a negativecharge. When bound to the clay in this manner, cetylpyridinium chloride is unavailablefor effective contact with tooth surfaces and microorganisms, thereby rendering theactive agent ineffective for its intended purpose.For this reason, cetylpyridinium chloride has not been totally effective in typical oralcare products for the treatment and / or prevention of gingivitis, plaque, periodontaldisease, and / or breath malodor. For example, toothpaste compositions typically includeanionic surfactants and artificial sweetening agents. These components of toothpastecompositions typically bind to cetylpyridinium chloride and thereby render it ineffectiveor substantially less effective as an antibacterial agent. Other components typicallyfound in a toothpaste composition such as abrasives also bind to cetylpyridiniumchloride. Accordingly, the use of cetylpyridinium chloride in toothpaste compositionshas been problematic. Even in commercial mouthwash products that containcetylpyridinium chloride, the availability of cetylpyridinium chloride at tooth surfaces isvery low and therefore its antibacterial effectiveness is limited.Further details of the particle may be found in WO2011 / 036031A1 (Unilever).The compound of zincIt is preferred that solubility of the compound of zinc at 20°C is 0.001 to 80 g / 100 gwater.It is preferred that the compound of zinc is at least one of zinc sulphate, zinc chloride,zinc nitrate, zinc citrate, zinc oxide, zinc lactate, zinc gluconate, zinc glycinate, zincoleate, zinc hydroxide or zinc peroxide, zinc oxide, zinc lactate, zinc chloride, zinccitrate, zinc acetate, zinc borate, zinc butyrate, zinc carbonate, zinc formate, zincgluconate, zinc glycerate, zinc glycolate, zinc phosphate, zinc picolinate, zincproprionate, zinc salicylate, zinc silicate, zinc stearate, zinc tartrate, zinc undecylenate,zinc phosphate, zinc ricinoleate or mixtures thereof. Both insoluble and soluble zincsalts may be used, alone or in combination, although the use of soluble zinc salts ispreferred (zinc salts with aqueous solubility greater than 0.01 g / 100g water).Preferably the compositions comprise at least one of zinc sulphate, zinc chloride, zincnitrate, zinc citrate, zinc oxide, zinc lactate, zinc gluconate, zinc glycinate, zinc oleate,zinc hydroxide or zinc peroxide. In some embodiments, a mixture of zinc sulphate andzinc citrate is preferred. In other embodiments, a mixture of zinc oxide and zincsulphate is preferred.It is particularly preferred that the personal care composition is an oral carecomposition. It is preferred that the composition is a toothpaste, toothpowder, breath-freshening spray, breath-freshening strip, breath freshening film, or a mouthwash.More preferably the composition is a toothpaste. Alternatively, and more preferably thecomposition is a mouthwash.One of the functions of a mouthwash and similar products is to remove unpleasantmouth odours and of making the user feel confident that their breath will not offend.However there remains a need to further mitigate mouth odours, especially frommouthwashes that are marketed as having mild formulations. Mild formulations containlow levels / no alcohol and no or low levels of anionic surfactants. The term "mouthwash"generally denotes liquid formulations which are used to rinse the surfaces of the oralcavity and provide the user with a sensation of oral cleanliness and refreshment. Themouthwash is an oral care composition that is not intentionally swallowed for purposesof systemic administration of therapeutic agents, but is applied to the oral cavity, usedto treat the oral cavity and then expectorated.Other IngredientsWhen the composition of the invention is an oral care composition it preferablycomprises one or more of the ingredients discussed hereinafter. The exact ingredientsand the dosage (wt%) would depend on the nature and type of the oral carecomposition. For example, while a toothpaste invariably comprises an abrasive, amouthwash does not need any abrasive.When said composition is a toothpaste, it preferably comprises 20 to 60 wt% of one ormore humectants.Humectants are generally included in toothpastes for a soft a supple mouth feel.Humectants also reduce the tendency of toothpastes to lose moisture. It is preferredthat the humectant is at least one of glycerine, sorbitol, maltitol and xylitol. Sorbitol isavailable as a 70% aqueous solution. Preferably the compositions comprise glycerineand sorbitol for a lubricated mouth feel, but their cumulative levels do not exceed thedisclosed upper limit. Lower humectant content provides an effective way to reduce thecost of the product.When the compositions of the invention is a toothpaste it preferably comprises anabrasive. The primary function of cleaning agents or abrasives is to provide thenecessary cleaning and stain removal to the toothpaste formulation. Typically, cleaningis directly correlated to the abrasivity of silica on tooth dentin and measured by RDA. Inother words, the higher the RDA, the higher the abrasivity. Even though this is typicallytrue, some of our cleaning grades can provide high cleaning efficiency at reduced levelof abrasion when compared with competitive cleaning grades.In one aspect the abrasive is silica. Such toothpastes are usually transparent ortranslucent gels. The term gel indicates physical appearance of the compositions. Thegel compositions are transparent to light, i.e. they allow visible light to pass through.Clear gel toothpastes are popular with consumers. When the oral care composition ofthe invention is a toothpaste in the form of a gel, it is preferred that the compositions donot comprise more than 5 wt%, preferably more than 2 wt% and more preferably morethan 1 wt% calcium-based abrasive. That might affect the transparent nature of thecompositions.On the other hand, there are some other types of dentifrice compositions that are notgels but are opaque. That is because such compositions usually contain opacifyingingredients such as chalk or other calcium-based abrasives.Preferably the composition comprises 5 to 20 wt% silica. Further preferably thecomposition the silica consists of medium- and high-abrasive silica, where medium-abrasive silica is in majority. Their relative proportions may vary. Preferably theabrasive silica is low refractive index silica with an apparent refractive index in therange of 1.41 to 1.47, preferably 1.435 to 1.445, preferably having a weight meanparticle size of between 5 and 15 μm, a BET (nitrogen) surface area of between 10 and100 m2 / g and an oil absorption of about 70 to 150 cm3 / 100 g. Examples of suitable lowrefractive index abrasive silicas having an R.I. of between 1.435 and 1.445 are Tixosil63 and 73 ex Rhone Poulenc; Sident 10 ex Degussa; Zeodent 113 ex Zeofinn; SorbosilAC 77 ex Ineos having an R.I. of approximately 1.440. Other examples include theSylodent and Syloblanc range of abrasive silicas from Grace.Further preferably the oral care compositions comprise 2 to 15 wt% thickening silica.The primary function of thickening silica is to build viscosity, without increasing the levelof abrasion (RDA) in the overall formulation. Also, they can be used as texturing agentsin formulations that use alternative abrasives other than silica. Our grades of thickeningsilicas can be categorized by their physical characteristics. These physicalcharacteristics have effect on the rheological properties of the formulation. Forexample, and perhaps more relevantly, the higher the oil absorption of the thickener,the higher the viscosity imparted to the formulation. In addition to having a substantialimpact on the viscosity of the toothpaste system, the thickening silica also plays a rolein the mouthfeel of the paste. If the level of the cleaning agent in the system is low,than the formulator may wish to use a less efficient thickener to achieve an overallsolids level consistent with the desired mouthfeel. In general, the paste formulationshould include at least 15% up to 30% total silica concentration. The split of thispercentage between thickener and cleaning agent depends on the choice of silicas,desired cleaning level, etc.This is especially the case when the compositions comprise silica as the abrasive. Awide variety of thickening silicas are commercially available to choose from. Whenpresent, preferred thickening silicas include AEROSIL T series from Degussa or theCAB-O-SIL series from Cabot Corporation, silica gels such as the SYLODENT or SYLOXseries from W. R.Grace & Co or precipitated silica such as ZEOTHIX 265from J. M. Huber Corporation. Useful silica thickeners also include ZEODENT 165,ZEODENT 163 and / or 167 and ZEOFREE 153, 177, and / or 265 silicas, all availablefrom J. M. Huber Corporation. Other preferred thickening silicas include MFIL, MFIL -P (From Madhu Silica), SIDENT 22 S and AEROSIL 200 (Ex. Evonik Industries),SYLODENT and PERKASIL thickening silicas from WR Grace & Company andTixosil 43 and 331 from Rhodia, synthetic finely divided pyrogenic silica such as thosesold under the trademarks SYLOID 244, SYLOID 266 and AEROSIL D-200.Alternatively, the oral care compositions of the invention comprise calcium -basedabrasive. It is particularly preferred abrasive is fine ground natural chalk (FGNC). It isobtained from limestone or marble. FGNC may also be modified chemically orphysically by coating during or after milling by heat treatment. Typical coating materialsinclude magnesium stearate and oleate. The morphology of FGNC may also bemodified during the milling process by using different milling techniques, for example,ball milling, air-classifier milling or spiral jet milling. FGNC can be used as the solecalcium containing abrasive. However, FGNC can also be used with other calciumcontaining abrasives to balance the abrasion.Other preferred calcium-based abrasives include dicalcium phosphate (DCP), calciumpyrophosphate and precipitated calcium carbonate (PCC). When a combination ofCalcium-based abrasives is used, it is preferred that FGNC is 35 to 100 %, morepreferably 75 to 100 % and especially from 95 to 100 % of the total abrasive. In suchcases, the balance, most preferably, is PCC.Other abrasives can also be used depending upon the intended degree of abrasionand the composition of the paste. These include synthetic abrasive polishing agentssuch as amorphous precipitated silica and silica gels. Other abrasives includemagnesium carbonate, sodium metaphosphate, potassium metaphosphate, zirconiumsilicate, potassium metaphosphate, magnesium orthophosphate, tricalcium phosphate,magnesium orthophosphate, trimagnesium phosphate, aluminum silicate, zirconiumsilicate and perlite.A mouthwash composition according preferably comprises an aqueous continuousphase. The amount of water generally ranges from 70 to 99 wt%. A mouthwashcomposition preferably comprises further ingredients to enhance performance and / orconsumer acceptability, such as the humectants and surfactants. The amount ofhumectant generally ranges from 4 to 20 percent, more preferably from 7 to 15 percentby weight based on the total weight of the mouthwash. Preferred humectants that arepresent at the above levels include polyols, particularly preferred is sorbitol.SurfactantsOral care compositions, especially toothpastes generally contain a surfactant, alsocommonly referred to as sudsing agent. Suitable surfactants are those which arereasonably stable and provide foam throughout a wider pH range. It is preferred thatcompositions comprise an anionic surfactant.Anionic surfactants useful herein include the water-soluble salts of alkyl sulfates havingfrom 8 to 20 carbon atoms in the alkyl radical (e.g., sodium alkyl sulfate) and the water-soluble salts of sulfonated monoglycerides of fatty acids having from 8 to 20 carbonatoms. Sodium lauryl sulfate and sodium coconut monoglyceride sulfonates areexamples of anionic surfactants of this type.Preferably the oral care compositions comprise 0.25 to 12 wt%, more preferably from0.5 to 8 wt%, and most preferably from 1 to about 6 wt% anionic surfactants.Some anionic surfactants, in particular, sodium lauryl sulphate itself have antibacterialeffect. Such action provides some degree of instant antibacterial effect. However, thiseffect is generally very short-lived. Other surfactants like nonionic, amphoteric orzwitterionic surfactants may also be included.Nonionic surfactants can be broadly defined as compounds produced by thecondensation of alkylene oxide groups (hydrophilic in nature) with an organichydrophobic compound which may be aliphatic or alkyl- aromatic in nature.Examples of suitable nonionic surfactants include poloxamers (sold under trade namePLURONIC ), polyoxyethylene, polyoxyethylene sorbitan esters (sold under tradename TWEENS), POLYOXYL 40 hydrogenated castor oil, fatty alcohol ethoxylates,polyethylene oxide condensates of alkyl phenols, products derived from thecondensation of ethylene oxide with the reaction product of propylene oxide andethylene diamine, ethylene oxide condensates of aliphatic alcohols, long chain tertiaryamine oxides, long chain tertiary phosphine oxides, long chain dialkyl sulfoxides, andmixtures of such materials.Further preferably the oral care compositions of the invention comprises a thickeningsystem which comprises thickening silica and at least one of carboxymethyl cellulose,xanthan gum or guar gum. Other binders and thickeners such as sodiumcarboxymethylcellulose, xanthan gum, gum arabic may also be included, as well assynthetic polymers such as polyacrylates and carboxyvinyl polymers such asCarbopol. It is preferred that dentifrice compositions of the invention comprise athickening system which comprises thickening silica and at least one of carboxymethylcellulose, xanthan gum or guar gum.Preferred oral care compositions comprise a binder, which lends a good structure tothe paste. Cellulosic binders are especially preferred. Preferred cellulosic bindersinclude cellulose ethers, which include hydroxyethyl cellulose (HEC), hydroxypropylcellulose (HPC), ethylhydroxyethyl cellulose (EHEC), carboxymethyl cellulose (CMC),carboxymethylhydroxyethyl cellulose (CMHEC), hydroxypropylhydroxyethyl cellulose(HPHEC), methyl cellulose (MC), methylhydroxypropyl cellulose (MHPC),methylhydroxyethyl cellulose (MHEC), carboxymethylmethyl cellulose (CMMC),hydrophobically modified carboxymethyl cellulose (HMCMC), hydrophobically modifiedhydroxyethyl cellulose (HMHEC), hydrophobically modified hydroxypropyl cellulose(HMHPC), hydrophobically modified ethylhydroxyethyl cellulose (HMEHEC),hydrophobically modified carboxymethylhydroxyethyl cellulose (HMCMHEC),hydrophobically modified hydroxypropylhydroxyethyl cellulose (HMHPHEC),hydrophobically modified methyl cellulose (HMMC), hydrophobically modifiedmethylhydroxypropyl cellulose (HMMHPC), hydrophobically modifiedmethylhydroxyethyl cellulose (HMMHEC), and hydrophobically modifiedcarboxymethylmethyl cellulose (HMCMMC).Other cellulosic binders include cationic hydroxyethyl cellulose (cationic HEC), cationichydrophobically modified hydroxyethyl cellulose (cationic HMHEC) and microcrystallinecellulose.A highly preferred binder is Sodium carboxymethyl cellulose (SCMC). Particularlypreferred sodium carboxymethyl celluloses include those with degree of substitution offrom 0.6 to 0.99, preferably from 0.7 to 0.95.Preferred toothpaste compositions may also include one or more other thickeningagents such as carboxyvinyl polymers which include carbomers which arecommercially available from B. F. Goodrich as the CARBOPOL series, includingCARBOPOL 934, 940, 941 and 956.Other preferred grades include acrylates / C10-30 alkyl acrylate crosspolymers which arecommercially available as ULTREZ 21, PEMULEN TR-1, and PEMULEN TR-2, fromNoveon Corporation. Preferred compositions can include 0.05 to 10 wt%, morepreferably 0.1 to 5 wt%, and even more preferably 0.25 to about 4 wt% of otherthickening agents.The oral care compositions of the invention may contain optional further ingredientssuch as cosmetically acceptable carriers like starch or sucrose.Preferred compositions can have alkali metal silicate. The alkali metal is sodium orpotassium, preferably sodium. Sodium silicate is generally available as 10 to 40 %aqueous solution, most common being 30 % solution. Sodium silicate is available asneutral sodium silicate or alkaline sodium silicate. Preferred toothpastes have neutralsodium silicate. Sodium silicate is available with varying ratios of Na2O: SiO2.Sodium silicate with Na2O: SiO2 ratio in the range of 3.0 to 3.8 is preferred, more highlypreferred range being 3.25 to 3.5. Preferred toothpastes include 0.1 to 5 wt% silicate(on dry weight basis). Thus, a 30 % solution of sodium silicate is added to thecomposition in an amount in the range of 0.3 to 16 wt%.Flavours such as peppermint and spearmint oils may also be included, as well aspreservatives, colouring agents, pH adjusting agents, sweetening agents and so on.Suitable flavoring components include oil of wintergreen, oil of peppermint, oil ofspearmint, clove bud oil, menthol, anethole, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, eugenol, parsley oil, oxanone, alpha-irisone, marjoram, lemon,orange, propenyl guaethol, cinnamon, vanillin, ethyl vanillin, heliotropine, 4-cis-heptenal, diacetyl, methyl-para-tert-butyl phenyl acetate, and mixtures thereof.Coolants may also be part of the flavor system. Preferred coolants are theparamenthane carboxyamide agents such as N-ethyl-p-menthan-3-carboxamide(known commercially as "WS-3") and mixtures thereof. The flavour is generally from0.001 to 5 wt%.Anti-caries agents such as sodium- and stannous fluoride, aminefluorides,monosodiumfluorophosphate, casein, plaque buffers such as urea, pyruvates, arginine,small peptides, calcium lactate, calcium glycerophosphate, strontium polyacrylates mayalso be included. A preferred anti-caries agent is sodium monofluorophosphate. Otheroptional ingredients include vitamins such as Vitamin C, and plant extracts.Desensitising agents such as potassium bicarbonate, potassium oxalate, potassiumnitrate as well as strontium salts may also be included.Buffers and salts to buffer the pH and ionic strength of the compositions may also beincluded. Liposomes and other encapsulates may also be used to improve delivery orstability of active ingredients.Furthermore, the oral care compositions may comprise anti-calculus agents such aalkali metal pyrophosphates, hypophosphite-containing polymers, organicphosphonates and phosphor-citrates.Other optional ingredients that may be included are e.g. bleaching agents such asperoxy compounds e.g. potassium peroxy diphosphate, effervescing systems such assodium bicarbonate / citric acid systems and colour change systems.The compositions of the invention may also contain coloured particles suspendedtherein, e.g. coloured silica agglomerates or other coloured particles to impart a"speckled" appearance to the dentifrices. The oral care compositions may also containstripes of a coloured paste, to provide for a visually clear gel-type dentifrice withcoloured stripes or a separate coloured phaseToothpastes with calcium containing abrasives especially chalk are prone to bacterialgrowth. Certain preservatives, e.g. methyl, ethyl, butyl, propyl and isopropyl esters ofparahydroxybenzoic acid may be particularly useful against bacterial growth. A mixtureof methyl, ethyl, butyl and propyl esters of parahydroxybenzoic acid is particularlypreferred.The activity of this mixture can be enhanced by adding phenoxyethanol. Formaldehydeand dimethyl hydantoin are other preferred preservatives. Preservatives are generallyincluded at 0.005 to 0.8 wt%.The oral care composition of the present invention is prepared by conventionalmethods of making oral care compositions. Such methods include mixing theingredients under moderate shear and atmospheric pressure.Typically, the composition is packaged.In toothpaste or gel form, the composition may be packaged in a conventional plasticlaminate, metal tube or a single compartment dispenser. The same may be applied todental surfaces by any physical means, such as a toothbrush, fingertip or by anapplicator directly to the sensitive area.The composition can be effective even when used in an individual's daily oral hygieneroutine. For example, the composition may be brushed onto the teeth. The compositionmay, for example, be contacted with the teeth for a time period of one second to 20hours. More preferably from 1 s to 10 hours, more preferably still from 10 s to 1 hourand most preferably from 30 s to 5 minutes. The composition may be used daily, forexample for use by an individual once, twice or three times per day. When the oral carecomposition is a dual-phase composition, the two phases of the composition are mixedduring application. The mixed phases are typically left on the teeth for from 3 minutesto 10 hours, more preferably from 3 minutes to 8 hours. The application may be carriedout one to five times monthly.In some embodiments, the methods comprise the step of rinsing the oral cavity with acomposition as described herein. In some embodiments, 5 ml or more of thecomposition is gargled. In some embodiments, 10 ml or more is used. In someembodiments, 10-50 ml is used. In some embodiments, 15-25 ml or more is used. Insome embodiments, 15 ml or more is used. In some embodiments, the individualgargles with the composition multiple times per day. In some embodiments, theindividual gargles with the composition on multiple days. In some embodiments, theindividual gargles with the composition every 4 to 6 hours up to 6 times per day.In accordance with a second aspect is disclosed non-therapeutic use of a compositionof the first aspect in the form of an oral care composition for treatment of bad breath.It is preferred that said oral hygiene is improved at least by a reduction in oral malodourof the user. Preferably the oral malodour is caused by the activity of salivary bacteriawhich generate volatile sulphurous compounds on at least the soft tissues inside saidoral cavity. Further preferably this malodour is reduced due to decrease in said volatilesulphurous compounds. In one aspect the use is for non-therapeutic purpose.Alternatively the use is for therapeutic purpose.Therapeutic treatments can be summarized as being measures directed to themaintenance (prophlyaxis) or restoration (therapy) of health. 'Therapy' is concernedwith bringing a body from a pathological state back to its normal, healthy state and withpreventing a pathological state. Treatment by therapy is defined as any treatment which is designed to cure, alleviate, remove or lessen the symptoms of, or prevent orreduce the possibility of contracting any disorder or malfunction of the human or animalbody.In accordance with a third aspect is disclosed a non-therapeutic method of treating badbreath comprising a step of applying a composition of the first aspect in the form of anoral care composition in the oral cavity.In accordance with a further aspect is disclosed a composition for use as amedicament in the treatment of halitosis or bad breath comprising:(i) 0.1 to 10 wt% of a bipolar antimicrobial particle whose precursor is anasymmetric 1:1 or 2:1:1 clay particle comprising alternating tetrahedral andoctahedral sheets terminating with a tetrahedral sheet at one external surfaceplane and an octahedral sheet at another external surface plane with anantibacterial agent attached to the coordinating cation on one of the said externalsurface plane, where the antibacterial agent is a quaternary ammoniumcompound; and,(ii) 0.001 to 10 wt% of a compound of zinc, wherein the median diameter of saidparticles (D50) is 0.1 to 10 μmPreferably the use of the composition as above brings about at least 30% reduction inat least one volatile sulphurous compound present in the oral cavity. Further preferablythe reduction is from 30 % to 90%. The volatile sulphurous compound is preferably atleast one of hydrogen sulfide, methyl mercaptan, or dimethyl sulfide.In accordance with a further aspect is disclosed a packaged oral care productcomprising an oral care composition of the first aspect in a package, preferably with aset of instructions to use the composition.The invention will now be further described with reference to the following non-limitingexamples.EXAMPLESExample-1: Oral care composition - Formulation and TestingA series of toothpastes were prepared. Details are included in Table 1. Composition 1,2 and 3 were outside the scope of the invention, PL indicates placebo formulation. Thecompositions Ex1 and Ex2 were within the scope of the invention.All the formulation of Table 1 including the placebo were subjected to malodourevaluation using the Soft Tissue Model described earlier. The observations, includingstatistical significance according to Anova and Tukey Tests are also summarised in thetable.Table 1Note*: the particle had 2.7% cetyl pyridinium chloride on kaolin. Therefore thecomposition of the particle was 2.7 wt% cetyl pyridnium chloride and 97.3 wt% kaolin.For example, in Ex2 the effective amount of quaternary ammonium compound was0.027 wt% in the toothpaste formulation. D50 of the particles was 0.5 μm.As far as the statistical significance is concerned, as the tests were paired-tests,compositions not connected by the same letter are significantly different.As ΔE signifies reduction in malodour, it is inversely proportional to the efficacy of thecomposition. In other words, a composition of lower ΔE is more efficacious than acomposition with higher ΔE.Therefore, the data in Table 1 indicates clearly that Ex1 and Ex2 brought about astatistically significant improvement in oral hygiene as compared to the placebo. thedata in Table 1 also indicates clearly that Ex1 and Ex2 brought about a significantimprovement in oral hygiene as compared to compositions 1,2 and 3 which werecomparative compositions outside the scope of the invention. The oral hygiene isimproved reduction in oral malodour of the user. According to the procedure, themalodour is caused by the activity of salivary bacteria which generate volatilesulphurous compounds on at least the soft tissues (tongue) inside said oral cavity. It isevidently clear that use of the composition according to the invention reduces oralmalodour by decreasing the volatile sulphurous compounds.The exemplified examples clearly indicate that the bipolar antimicrobial particleinteracts synergistically with a compound of zinc, (in the example, zinc sulphate) toprovide a variety of antimicrobial benefits inter alia to control or mitigate malodour,especially oral malodour. Accordingly, this synergistic interaction can be utilised andprovided to consumers in a variety of home care and personal care compositions.
Claims
1. A composition comprising: i) 0.1 to 10 wt% of a bipolar antimicrobial particle whose precursor is an asymmetric 1:1 or 2:1:1 clay particle comprising alternating tetrahedral and octahedral sheets terminating with a tetrahedral sheet at one external surface plane and an octahedral sheet at another external surface plane with an antibacterial agent attached to the coordinating cation on one of the said external surface plane, where the antibacterial agent is a quaternary ammonium compound; and, ii) 0.001 to 10 wt% of a compound of zinc, wherein the median diameter of said particles (D50) is 0.1 to 10 μm, wherein said compound of zinc is zinc sulphate, zinc chloride, zinc nitrate, zinc citrate, zinc oxide, zinc lactate, zinc gluconate, zinc glycinate, zinc oleate, zinc hydroxide or zinc peroxide.
2. A composition as claimed in claim 1 wherein said composition is a home care composition.
3. A composition as claimed in claim 2 wherein said home care composition is a laundry detergent, a fabric conditioner, a floor cleaning composition, a toilet cleaning composition, a dishwash composition or a surface sanitising composition.
4. A composition as claimed in claim 1 wherein said composition is a personal care composition.
5. A composition as claimed in claim 4 wherein said personal care composition is a leave-on skin lotion, cream, antiperspirant, deodorant, lipstick, foundation, mascara, sunless tanner, sunscreen, serum, shampoo, hair conditioner, hair serum, hair gel, oral care composition, handwash, bodywash, shower gel or soap.
6. An oral care composition as claimed in any of claims 1 to 5 wherein said quaternary ammonium material is at least one of cetylpyridinium chloride (CPC), cetyltrimethylammonium chloride (CTAC), cetyltrimethylammonium bromide (CTAB), benzalkonium chloride (BKC), benzethonium chloride, cetrimide, quaternium, tetrabutyl ammonium bromide, undecylenamido propyltrimonium methosulphate, methylbenzethonium chloride, cetethyldimonium bromide, cetromonium tosylate, cocotrimonium chloride, dodecylbenzyltrimonium chloride, lauryl isoquinolium bromide, laurylpyridinium chloride, dequalinium chloride or domiphen bromide.
7. An oral care composition as claimed in any one of claims 1 to 6 wherein solubility of said compound of zinc at 20°C is 0.001 to 80 g / 100 g water.
8. A composition as claimed in any of claims 1 to 7 comprising 0.1 to 10 wt% bipolar antimicrobial particle.
9. A composition as claimed in any of claims 4 to 8 wherein said personal care composition is an oral care composition.
10. Non-therapeutic use of a composition as claimed in any of claims 1 to 9 for treatment of bad breath.
11. A non-therapeutic method of treating bad breath comprising a step of applying a composition as claimed in any of claims 1 to 9 in the oral cavity.
12. A composition for use as a medicament in the treatment of halitosis or bad breath, comprising: i) 0.1 to 10 wt% of a bipolar antimicrobial particle whose precursor is an asymmetric 1:1 or 2:1:1 clay particle comprising alternating tetrahedral and octahedral sheets terminating with a tetrahedral sheet at one external surface plane and an octahedral sheet at another external surface plane with an antibacterial agent attached to the coordinating cation on one of the said external surface plane, where the antibacterial agent is a quaternary ammonium compound; and, ii) 0.001 to 10 wt% of a compound of zinc, wherein the median diameter of said particles (D50) is 0.1 to 10 μm, wherein said compound of zinc is zinc sulphate, zinc chloride, zinc nitrate, zinc citrate, zinc oxide, zinc lactate, zinc gluconate, zinc glycinate, zinc oleate, zinc hydroxide or zinc peroxide.
